Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 9.386.306.235.123.73

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.38 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12
Mar20203.73

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12
37.27
Mar2020 3.73 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,141.3 Cr -4.2% -6.4% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,204.0 Cr -1% -0.5% 13.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-4.2%

-6.4%

-8.1%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses